CONNECT WITH US
Tech

Tech

The small African lab sounding the alarm on AI bioweapons

Rest of World logo

Published on

Add as a preferred source on Google
The small African lab sounding the alarm on AI bioweapons

MinoHealth researchers in Ghana jailbroke their own LLM as a test. What emerged were thousands of toxin recipes—and an urgent push for regulation.

Out of curiosity, researchers at a small artificial intelligence lab in Accra, Ghana, removed the guardrails on their drug discovery AI model in 2024. They asked it to design toxins instead.

The model produced designs for 1,020 proteins and 5,000 small molecules. The researchers never made any of them in a lab, but software that predicts how poisonous a substance is scored all of them as likely toxic. Some of them resembled ricin, a deadly poison. The study was uploaded to the preprint server arXiv in May 2025.

“We were all shocked,” Darlington Akogo, founder of MinoHealth AI Labs, told Rest of World. 

For Akogo, the results also raised a new question: If someone took designs like these to a company that makes DNA to order, would anyone stop them? 

Across Africa, the need to regulate DNA synthesis providers is now echoing through the highest levels of government, Brenda Obuya, a senior official at Kenya’s Ministry of Information, Communications and the Digital Economy, told Rest of World. 

Akogo has traveled the world warning that AI poses an existential bioweapons threat. , last year. He discussed the broader risk over dinner with Microsoft co-founder Bill Gates in 2023, whom he described as “on the fence” at the time. This year, Gates has issued numerous public warnings. I. has crossed the threshold that its ability to empower a bioterrorist to kill hundreds of millions, that exists today,” he said on The Ezra Klein Show in September.


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.